AdverseEvent.ai

Shower To Shower

FDA adverse event reports for this product.

296
Total reports
Ovarian Cancer
Top reaction

Top reactions reported

MedDRA Preferred Terms, ranked by frequency in the reports. Shown as percent of all reports for this product. A single report can list multiple reactions, so percentages can sum above 100%.

Ovarian Cancer
42%
Ovarian Cancer Stage Iii
18%
Ovarian Cancer Stage I
12%
Injury
7%
Death
6%
Ovarian Cancer Stage Iv
6%
Fallopian Tube Cancer
4%
Ovarian Cancer Stage Ii
4%
Endometrial Cancer Stage I
2%
Malignant Peritoneal Neoplasm
2%
Fallopian Tube Cancer Stage Iii
2%
Uterine Cancer
1%
Exposure To Chemical Pollution
1%
Neoplasm Malignant
1%
Retroperitoneal Cancer
1%

Outcomes

How the reports resolved, shown as percent of all reports. Outcomes can overlap (one report can have multiple outcomes), so percentages do not sum to 100%.

Other Serious or Important Medical Event
88%
Death
33%
Hospitalization
26%
Life Threatening
1%
Congenital Anomaly
<1%
Disability
<1%

What to do next

Tools for reporting or tracking adverse events — both for cosmetics and the wider universe of prescription and OTC drugs.

Share this page

About this data

This page summarizes adverse event reports from the FDA's adverse event reporting system for cosmetic products. Reactions are coded in MedDRA. Reports come from consumers, health professionals, and industry. The presence of a report does not establish that the product caused the event - it only reflects what was reported to FDA.

Limitations: The public dataset does not include free-text case narratives, only structured fields.

Data as of June 15, 2026. Source: FDA.